According to the organisation, there have been 445,419 reported across the world today. The WHO also reported 6,521 deaths had been recorded as several countries are crippled by the second wave of the virus. According to the WHO’s figures, there have now been 41,570,883 cases across the world.
There have also 1,134,940 deaths of the virus, with approximately 218 experiencing outbreaks.
Such is the devastating impact of the virus, Director-General Tedros Adhanom Ghebreyesus claimed the world is now at a critical juncture.
He also warned some states may face the prospect of a complete collapse of their respective health systems.
The director-general paid particular attention to the northern hemisphere where cases are rising sharply in France, the UK, Spain, Belgium and France.
He said today: “We are at a critical juncture in the COVID-19 pandemic, particularly in the Northern hemisphere.
“The next few months are going to be very tough and some countries are on a dangerous track.
“We urge leaders to take immediate action, to prevent further unnecessary deaths, essential health services from collapsing and schools shutting again.
“As I said it in February and I’m repeating it today: This is not a drill.”
According to their figures, Belgium’s 14-day average of infections per 100,000 stands at 1019.8.
The Czech Republic is the highest with 1148.5, while the UK is recording 373.1.
Today, there were 20,540 cases of coronavirus reported in the UK across all settings.
There were also 224 deaths taking the total in the UK to 44,571.
As countries across the world look for a vaccine for the virus, the WHO has also revealed it will soon publish guidance on the drug, Remdesivir.
The drug has been given approval in the US to treat infections.
Janet Diaz, the WHO’s top official for clinical care responses said: “We would anticipate that the guidelines will be available within three to four weeks.”
In the UK, there are currently six drug treatments currently undergoing trials.
The vaccine being developed by Oxford University and AstraZeneca is the frontrunner and is currently progressing through phase 3 trials before being cleared for use.
Published at Fri, 23 Oct 2020 16:23:00 +0000